UC selected to test new vaccine
UC will serve as one of several international locations to test an investigational vaccine to possibly treat cytomegalovirus in people getting kidney transplants. The study is designed to learn more about the safety and effectiveness of the HB-101 vaccine at preventing the CMV infection in people who are CMV-negative who receive kidney transplants from living donors who are CMV-positive.
U.S. News & World Report: A patient's guide to norovirus
Carl Fichtenbaum, MD, professor in the Division of Infectious Diseases in the Department of Internal Medicine at the UC College of Medicine, provides information on the risk factors of contracting norovirus in an article in U.S. News & World Report.